Best Chinese Stocks To Watch Today - November 16th

• Zoom Video Indicates Normalization Ends and Growth Resumes

Diageo, UP Fintech, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are shares of companies that are primarily based in, operate in, or derive significant revenue from mainland China, Hong Kong, or other Chinese jurisdictions and can be listed on domestic exchanges (Shanghai, Shenzhen), in Hong Kong (H‑shares), or on foreign exchanges via ADRs or offshore listings. For investors, they offer exposure to the Chinese economy but carry specific considerations such as differing listing types, regulatory and political risks, currency and accounting differences, and variable liquidity. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

• Modelo Sale Success Propels Constellation Brands In The Market

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

• 3 Beer Stocks to Tap into if You're Ready for Some Football

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

See Also

• MarketBeat's Top Five Stocks to Own in November 2025
• 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
• Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
• Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
• 3 Under-the-Radar AI Stocks to Buy on the Dip
• Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Diageo Right Now?

Before you consider Diageo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.

While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here